Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,596.28
(
0.41%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 109607

Monday, 11/29/2010 8:21:20 PM

Monday, November 29, 2010 8:21:20 PM

Post# of 257302

EXEL—"evidence of bone scan resolution (partial or complete)" occurred in 19 out of 20 patients treated with XL184.

This is not a quantitative finding, but rather the qualitative impression of investigators based on visual inspection of the scans. There is no formal definition of “bone scan resolution” in prostate cancer.

Is that NOT good enough for approval?

Of course not, and even EXEL has not claimed that it is. Was your question serious?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today